Early-stage TNBC: ixabepilone safer, as effective as paclitaxel

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Takeaway
  • In patients with early-stage triple-negative breast cancer (TNBC), the microtubule stabilizer ixabepilone (Ixempra) is safer and as effective as paclitaxel (Taxol) in combination with AC (doxorubicin [Adriamycin]/cyclophosphamide [Cytoxan]).
Why this matters
  • Ixabepilone offers a treatment...